Enzymology and drug discovery
Professor of Biochemistry at Uppsala University in Sweden since 2002. Platform Scientific Director at the SciLifeLab infrastructure unit for Biophysical Screening and Characterization and co-founder of Beactica Therapeutics AB.
Specialist in enzymology and drug discovery with a focus on biomolecular interaction analysis for detailed studies of enzyme-inhibitor interactions and other important recognition processes in the life science area. The work has involved studies of a variety of enzymes, primarily proteases and polymerases from viruses and other infectious organisms, or involved in important disease processes. Extensive experience of the commercial drug discovery process through over 30 years of collaborative research with partners in pharmaceutical and biotechnological industry.
Please contact the directory administrator for the organization (department or similar) to correct possible errors in the information.